Propionate and butyrate counteract renal damage and progression to chronic kidney disease
Short-chain fatty acids (SCFAs), mainly acetate, propionate and butyrate, are produced by gut microbiota through fermentation of complex carbohydrates that cannot be digested by the human host. They affect gut health and can contribute at the distal level to the pathophysiology of several diseases,...
| Authors: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Status: | Published version |
| Publication Date: | 2024 |
| Country: | España |
| Institution: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repository: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/381940 |
| Online Access: | http://hdl.handle.net/10261/381940 https://api.elsevier.com/content/abstract/scopus_id/85210573436 |
| Access Level: | Open access |
| Keyword: | AKI-to-CKD transition Acute kidney injury Fibrosis Inflammation Short-chain fatty acids |
| Summary: | Short-chain fatty acids (SCFAs), mainly acetate, propionate and butyrate, are produced by gut microbiota through fermentation of complex carbohydrates that cannot be digested by the human host. They affect gut health and can contribute at the distal level to the pathophysiology of several diseases, including renal pathologies. |
|---|